Zyter ThermalAlert Screening System for COVID-19 Goes Live at Several New Jersey Hospitals

Zyter®, a leading digital health and IoT-enablement platform, today announced that Zyter ThermalAlert™, a smart thermal scanning and imaging system for automated, accurate, mass temperature screening, has gone live at three New Jersey hospitals operated by CarePoint Health; Bayonne Medical Center, Christ Hospital in Jersey City, and Hoboken University Medical Center.

With a detection time of less than one second and accuracy of plus/minus 0.5 degrees Fahrenheit, smart alerts from thermal imaging cameras are sent instantly to medical staff or security personnel monitors, computers or mobile devices.  Those individuals with abnormal temperature readings can then be redirected to a different entrance for additional testing or care.

Zyter will deploy 12 ThermalAlert imaging cameras in a stand-alone configuration, divided among the three facilities.  Three cameras will be deployed at main entrances while a fourth camera will be deployed in an unspecified location.

Zyter ThermalAlert is a dual spectrum, thermal imaging solution that delivers continuous, real-time, non-contact temperature monitoring.  It is able to measure the body temperature (between 86 degrees F to 113 degrees F) of up to 6 people simultaneously within the temperature detection zone from a distance of up to 20 feet, much farther than the 1-6 feet industry average.  The Centers for Disease Control and Prevention noted that 83 to 99 percent of people with a coronavirus infection will have a fever.1

“We are honored to partner with CarePoint to increase workplace safety in these unprecedented times,” said Sanjay Govil, founder and chairman of Zyter, Inc. “ThermalAlert can be deployed in less than 48 hours and provides an efficient and unobtrusive solution for screening thousands of people while minimizing staff resources and risk.”

“At CarePoint hospitals we are going the extra mile for our patients, employees and visitors,” said Dr. Achintya Moulick, CEO at CarePoint Health.  “This will create a safer environment for everyone as we go ahead scheduling elective surgeries.”

“Temperature scanning systems provide fast and reliable results on easy-to-read digital screens and allow us to triage every visitor and employee who enters one of our three facilities, creating another layer of safety for our patients and staff,” said Vijay Singh, chief hospital executive at Bayonne Medical Center.

The Zyter core platform is HIPAA, FedRAMP, and FISMA compliant.  Zyter ThermalAlert is currently deployed at a military treatment facility (MTF), retail, commercial healthcare, and transportation facilities nationwide, as has been used at live events and entertainment facilities.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”